TY - JOUR
T1 - What is ‘LDL cholesterol’?
AU - Holmes, Michael V.
AU - Ala-Korpela, Mika
PY - 2019/1
Y1 - 2019/1
N2 - LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’. We advocate the need for awareness of the potential implications.
AB - LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’. We advocate the need for awareness of the potential implications.
UR - http://www.scopus.com/inward/record.url?scp=85060957996&partnerID=8YFLogxK
U2 - 10.1038/s41569-019-0157-6
DO - 10.1038/s41569-019-0157-6
M3 - Comment/debate (Academic Journal)
C2 - 30700860
AN - SCOPUS:85060957996
SN - 1759-5002
VL - 16
SP - 197
EP - 198
JO - Nature Reviews Cardiology
JF - Nature Reviews Cardiology
IS - 4
ER -